| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.008 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |